The multicountry EFFORT trial compares shorter radical-cure strategies under unsupervised, real-world use in people meeting a G6PD activity threshold. Its practical value lies in balancing recurrence prevention and adherence against haemolysis risk rather than treating convenience as the only outcome.
Key findings
- The multicountry EFFORT trial compares shorter radical-cure strategies under unsupervised, real-world use in people meeting a G6PD activity threshold. Its practical value lies in balancing recurrence prevention and adherence against haemolysis risk rather than treating convenience as the only outcome.
Why this matters globally
This work adds internationally comparable evidence in Health sciences and defines questions for replication in other populations or systems. Its global value lies in the evidence and transferable reasoning, not in a single impact score.
Thai researcher contribution
Thailand-linked authors and Mahidol Oxford Tropical Medicine Research Unit, Mahidol University contribute to the research network behind this work. Thai participation is identified from bibliographic affiliations and should be checked against the author list and source article.
Limitations to consider
Eligibility can limit generalisability; long-term and real-world outcomes remain important, and secondary or subgroup findings should not be overinterpreted.